[NBIX] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
02-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 8.42%
YoY- -7.12%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 6,335 0 0 0 0 15,000 0 -
PBT -59,985 -78,326 -44,659 -36,887 -40,280 -19,264 -29,315 61.24%
Tax 4,767 -1,606 -2,024 -1,549 -1,548 -1,593 -1,692 -
NP -59,985 -78,326 -44,659 -36,887 -40,280 -19,264 -29,315 61.24%
Tax Rate - - - - - - - -
Total Cost 66,320 78,326 44,659 36,887 40,280 34,264 29,315 72.41%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin -946.88 0.00 0.00 0.00 0.00 -128.43 0.00 -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -0.68 -0.90 -0.51 -0.43 -0.46 -0.22 -0.34 58.80%
EPS Diluted -0.68 -0.90 -0.51 -0.43 -0.46 -0.22 -0.34 58.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.